Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 206564-00-3 | MDL No. : | MFCD01940445 |
Formula : | C8H7N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JTOGGBLTIHXWEH-UHFFFAOYSA-N |
M.W : | 161.16 | Pubchem ID : | 3804989 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.14 |
TPSA : | 64.94 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.84 cm/s |
Log Po/w (iLOGP) : | 1.6 |
Log Po/w (XLOGP3) : | 0.62 |
Log Po/w (WLOGP) : | 1.33 |
Log Po/w (MLOGP) : | -0.32 |
Log Po/w (SILICOS-IT) : | 1.22 |
Consensus Log Po/w : | 0.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.84 |
Solubility : | 2.32 mg/ml ; 0.0144 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.56 |
Solubility : | 4.46 mg/ml ; 0.0276 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.01 |
Solubility : | 0.156 mg/ml ; 0.000971 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.35 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | With potassium carbonate In DMF (N,N-dimethyl-formamide) at 100℃; for 21 h; | A suspension of 3-(dimethylamino)-1-(2-furyl)-2-propen-1-one (5.0 g, 30.3 mmol), guanidine hydrochloride (5.8 g, 60.7 mmol) and potassium carbonate (8.4 g, 60.9 mmol) in N, N-dimethylformamide (50 ml) was stirred at 100°C for 21 hours. After cooling as it was, the reaction mixture was diluted with ice water (250 ml). The resulting solid was collected by filtration and washed with water, to give the title compound (4.19 g, 86percent) as a pale brown solid.1H NMR (400 MHz, DMSO-d6) δ ppm; 6.66 (2H, br s), 6.68 (1H, dd, J = 2.0, 3.2 Hz), 6.88 (1H, d, J = 5.2 Hz), 7.17 (1H, dd, J = 0.8, 3.2 Hz), 7.88 (1H, dd, J = 0.8, 2.0 Hz), 8.28 (1H, d, J = 5.2 Hz); MS m/e (ESI) 162 (MH+). |
[ 99844-02-7 ]
4-(4-Methoxyphenyl)pyrimidin-2-amine
Similarity: 0.70
[ 2164-67-2 ]
(2-Aminopyrimidin-4-yl)methanol
Similarity: 0.68
[ 165807-05-6 ]
4-Dimethoxymethylpyrimidin-2-ylamine
Similarity: 0.67
[ 1009734-33-1 ]
5-(tert-Butoxy)quinazoline-2,4-diamine
Similarity: 0.67
[ 96799-02-9 ]
5-(Furan-2-yl)-1H-pyrazol-3-amine
Similarity: 0.59
[ 99844-02-7 ]
4-(4-Methoxyphenyl)pyrimidin-2-amine
Similarity: 0.70
[ 2164-67-2 ]
(2-Aminopyrimidin-4-yl)methanol
Similarity: 0.68
[ 165807-05-6 ]
4-Dimethoxymethylpyrimidin-2-ylamine
Similarity: 0.67